mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.5 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.5 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |